tumor molecular profiling
Showing 9976 - 10000 of >10,000
Xpert® Bladder Cancer Monitor Test.
Completed
- Non-Invasive Bladder Urothelial Carcinoma
- +2 more
- Xpert® Bladder Cancer Monitor Test
-
Montpellier, Hérault, FranceClinique Beau Soleil
Feb 8, 2021
Bone-related Genetic Variants in Families
Terminated
- Skeletal Dysplasia
- Samples With DNA
-
Doha, QatarHamad Medical Corporation
Jul 29, 2020
Stomach Tumors, Paclitaxel, Peritoneal Metastases Trial in Seoul (Paclitaxel)
Recruiting
- Stomach Neoplasms
- +2 more
-
Seoul, Korea, Republic ofGastric cancer center, Seoul St. Mary's Hospital
Jul 1, 2021
Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin
Recruiting
- Hepatocellular Carcinoma
- Raltitrexed, oxaliplatin (SALOX) treatment
- Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 17, 2022
Tumors Trial run by the NCI (Nilotinib and Paclitaxel)
Recruiting
- Neoplasms
- Nilotinib and Paclitaxel
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Melanoma (Skin) Trial in La Jolla (recombinant interferon alfa-2b, azacitidine)
Completed
- Melanoma (Skin)
- recombinant interferon alfa-2b
- azacitidine
-
La Jolla, CaliforniaRebecca and John Moores UCSD Cancer Center
Mar 1, 2021
LAMP Assay Versus PCR for Detection of blaNDM-1 and blaKPC Genes
Not yet recruiting
- Gene Amplification
- (no location specified)
Jul 18, 2020
Advanced Solid Tumor Trial in Philadelphia (Low dose radiation and ALA)
Recruiting
- Advanced Solid Tumor
- Low dose radiation and ALA
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 18, 2022
Low Risk Differentiated Thyroid Cancer Trial in Villejuif (rhTSH stimulation, I131, Follow up)
Active, not recruiting
- Low Risk Differentiated Thyroid Cancer
- rhTSH stimulation
- +2 more
-
Villejuif, Val De Marne, FranceInstitut Gustave Roussy
Dec 7, 2021
Abatacept Discontinuation Using Test Reflecting Immunological
Recruiting
- Rheumatoid Arthritis
-
Rouen, FranceRouen University Hospital
Aug 11, 2020
Anthracycline Related Cardiotoxicity in Breast Cancer Trial in Lubbock (sulforaphane, Placebo Oral Tablet)
Recruiting
- Anthracycline Related Cardiotoxicity in Breast Cancer
- sulforaphane
- Placebo Oral Tablet
-
Lubbock, TexasTexas Tech University Health Sciences Center
Jul 18, 2022
Immune Checkpoint Inhibitors for Solid Neoplasms
Recruiting
- Cancer
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 20, 2021
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022
Hysteroscopic Myomectomy for Submucosal Myomas Without Energy
Recruiting
- Hysteroscopic Myomectomy
-
Yiwu, Zhejiang, ChinaXu Wanwan
Nov 28, 2023
Temporal Bone Squamous Cell Carcinoma Trial in Guangzhou (Paprizumab combined with cisplatin and 5-FU)
Recruiting
- Temporal Bone Squamous Cell Carcinoma
- Paprizumab combined with cisplatin and 5-FU
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 5, 2022
Cancer Associated Thrombosis : What is Proportion of Patients
Recruiting
- Venous Thromboembolism
- Cancer
- data collection
-
Amiens, France
- +2 more
Apr 16, 2021
Differential Leucocyte Count and Covid-19 Diagnosis
Withdrawn
- SARS-CoV-2 Infection Covid19
- Differential Leucocyte Count (CLDC) device and algorithm
-
Pozzilli, IS, ItalyIRCCS INM Neuromed, Department of Epidemiology and Prevention
Jan 11, 2022
Malignant Tumors of Digestive Organs Trial in Hefei (gucy2c cart cells)
Not yet recruiting
- Malignant Neoplasms of Digestive Organs
- gucy2c cart cells
-
Hefei, Anhui, ChinaAnhui provincial cancer hospital
Feb 28, 2021
Critical Ill Patients, Patients Needing Continuous Renal Replacement Therapy Trial in Beijing (AN69ST hemofilter, AN69
Completed
- Critical Ill Patients
- Patients Needing Continuous Renal Replacement Therapy
- AN69ST hemofilter
- AN69 hemofilter
-
Beijing, Beijing, ChinaRenal division,department of Medcine,Peking University First Hos
May 22, 2021
Multiple Sclerosis, Relapsing-Remitting Trial in Birmingham (Spinal Manipulation, Sham Spinal Manipulation)
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Spinal Manipulation
- Sham Spinal Manipulation
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 30, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)
Active, not recruiting
- Colorectal Cancer
- Metastatic Cancer
- FOLFOX regimen
- +7 more
-
New Brunswick, New Jersey
- +1 more
Jul 1, 2022
Breast Cancer Trial in Honolulu (Exercise)
Recruiting
- Breast Cancer
- Exercise
-
Honolulu, HawaiiUniversity of Hawaii Cancer Center
Sep 22, 2021